Clinical trials
3 active studies led by ReValve Solutions Inc., of 3 in all
Source: ClinicalTrials.gov, Studies with ReValve Solutions Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 3Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by ReValve Solutions Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on ReValve Solutions Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies ReValve Solutions Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with ReValve Solutions Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show ReValve Solutions Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Healthcare Topics
The topics of the markets ReValve Solutions Inc. is in.
From our blog
Stories on the topics ReValve Solutions Inc. works in.
Omega-3: Heart, Brain and the Evidence Debate
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Angiography: Seeing Inside the Blood Vessels
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Read
Angioplasty Balloons and Heart Care in India
In 2017 India capped coronary stent prices, cutting drug-eluting stent prices by about 85%. Heart disease is…
Read